Faruqi & Faruqi Investigation: MedAssets, Inc.
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of MedAssets, Inc. (“MedAssets” or the “Company”) (NasdaqGS:MDAS) for potential breaches of fiduciary duties in connection with the sale of the Company to Pamplona Capital Management for approximately $2.7 billion. The Company’s stockholders will only receive $31.35 in cash for each share of Company common stock they own.
If you own common stock in MedAssets and wish to obtain additional information and protect your investments free of charge, please contact Juan Monteverde, Esq. either via e-mail at firstname.lastname@example.org or by telephone at (877) 247-4292 or (212) 983-9330.